-
Featured
Interventional Cardiology Studies Boost Safety in TAVR, PCI
A Massachusetts General Hospital interventional cardiologist is using research to lower bleeding risk and incidence of stroke in percutaneous coronary intervention and transcatheter aortic valve replacement.
-
Cerebral Embolic Protection Device May Not Reduce Stroke Risk After Transcatheter Aortic Valve Implantation
Dhaval Kolte, MD, PhD, and Sammy Elmariah, MD, MPH, and colleagues determined from a nationally representative database that using a cerebral embolic protective device during transcatheter aortic valve implantation was not associated with lower rates of in-hospital stroke, transient ischemic attack or mortality.
-
Advancing Complex Coronary Artery Disease Interventions
Massachusetts General Hospital interventional cardiologists are studying best practices and novel therapeutics to better manage complex coronary artery disease patients.
-
TAVR Team Continuously Innovating to Treat Aortic Stenosis
Massachusetts General Hospital researcher-clinicians have improved transcatheter aortic valve replacement (TAVR) to make it available to all patients with aortic stenosis.
-
Review: Optimal Anticoagulation After Bioprosthetic Valve Replacement
Massachusetts General Hospital researchers review medical society guidelines about anticoagulation and antiplatelet therapy after bioprosthetic aortic and mitral valve replacement—and propose their own strategies.
-
Review: Managing Severe Aortic Stenosis in the COVID-19 Era
In the absence of medical society guidelines, Massachusetts General Hospital cardiologists recommend best practices for managing patients with severe aortic stenosis under the resource constraints imposed by COVID-19.
Interventional Cardiology Contributors
-
Darshan Doshi, MD
Interventional Cardiologist, Massachusetts General Hospital
Recent Article
Advancing Complex Coronary Artery Disease Interventions
-
Farouc A. Jaffer, MD, PhD
Director, Coronary Intervention, Massachusetts General Hospital, Director, MGH Chronic Total Occlusion (CTO) Percutaneous Coronary Intervention (PCI) program, Associate Physician, MGH Cardiology, Department of Medicine
Recent Article
Reducing Post-Thrombotic Syndrome Through Reperfusion After DVT May Be Time-Sensitive
-
Nathaniel B. Langer, MD, MSc
Cardiac Surgeon, Massachusetts General Hospital, Assistant Professor of Surgery, Harvard Medical School
Recent Article
TAVR Team Continuously Innovating to Treat Aortic Stenosis
-
Rahul Sakhuja, MD
Interventional Cardiologist, Corrigan Minehan Heart Center, Massachusetts General Hospital
Recent Article
Interventional Cardiology Studies Boost Safety in TAVR, PCI
-
Sammy Elmariah, MD, MPH
Director of Interventional Cardiology Research, Massachusetts General Hospital, Assistant Professor of Medicine, Harvard Medical School
Recent Article
Cerebral Embolic Protection Device May Not Reduce Stroke Risk After Transcatheter Aortic Valve Implantation
-
Serguei Melnitchouk, MD, MPH
Cardiac Surgeon, Co-Director, Heart Valve Program, Quality Director, Division of Cardiac Surgery
Recent Article
Review: Optimal Anticoagulation After Bioprosthetic Valve Replacement
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.